Previous Article | Next Article 
Applied and Environmental Microbiology, August 2000, p. 3421-3426, Vol. 66, No. 8
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Tandem Repeat of a Transcriptional Enhancer
Upstream of the Sterol 14
-Demethylase Gene (CYP51) in
Penicillium digitatum
Hiroshi
Hamamoto,1,2,*
Koji
Hasegawa,1
Ryoji
Nakaune,3
Young Jin
Lee,1
Yoshiyuki
Makizumi,1
Katsumi
Akutsu,4 and
Tadaaki
Hibi1
Department of Agricultural and Environmental
Biology, The University of Tokyo, Bunkyo-ku, Tokyo
113-8657,1 Bio-oriented Technology
Research Advancement Institution (BRAIN), Nisshin, Ohmiya, Saitama
331-0044,2 National Institute of
Fruit Tree Science, Akitsu, Hiroshima 729-2494,3
and Faculty of Agriculture, Ibaraki University, Ami-machi,
Ibaraki 300-0393,4 Japan
Received 15 October 1999/Accepted 1 June 2000
 |
ABSTRACT |
We investigated the mechanism of resistance to demethylation
inhibitors (DMI) in Penicillium digitatum by isolating the
CYP51 gene, which encodes the target enzyme
(P45014DM) of DMI, from three DMI-resistant and three
DMI-sensitive strains. The structural genes of all six strains were
identical, but in the promoter region, a unique 126-bp sequence was
tandemly repeated five times in the DMI-resistant strains and was
present only once in the DMI-sensitive strains. Constitutive expression
of CYP51 in the resistant strains was about 100-fold higher
than that in the sensitive strains. We introduced CYP51,
including the promoter region, from a DMI-resistant strain into a
DMI-sensitive strain, which rendered the transformants DMI resistant
and increased CYP51 expression. We also found that if the
number of copies of the repeat was reduced to two, resistance and
CYP51 expression also decreased. These results indicate
that the 126-bp unit acts as a transcriptional enhancer and that a tandem repeat of the unit enhances CYP51 expression,
resulting in DMI resistance. This is a new fungicide resistance
mechanism for filamentous fungi.
 |
INTRODUCTION |
Demethylation inhibitors (DMIs) are
widely used as fungicides in agriculture and medicine. In the 1970s,
the development of resistance to DMI fungicides under practical
conditions was thought to be unlikely (9, 16). However, in
practice, DMI-resistant strains occur widely in several important plant
and animal pathogens, such as Erysiphe graminis,
Sphaerotheca fuliginea, Pyrenophora teres
(12), and Candida albicans (11),
causing acute problems in crop production and in the treatment of
candidiasis of AIDS patients. Determining the mechanism of resistance
is, therefore, quite important.
We previously showed that an ATP-binding cassette (ABC) transporter
gene, PMR1, is involved in DMI resistance in
Penicillium digitatum by disrupting the PMR1 gene
and concomitantly increasing sensitivity to DMI fungicides
(21). PMR1 expression is strongly induced by
fungicide treatment in both DMI-sensitive and DMI-resistant strains,
but the constitutive expression level of PMR1 in the resistant strain was relatively higher than that in the sensitive strain (21). ABC transporter-mediated resistance to
toxicants in yeast and human cells is a consequence of increased
constitutive expression of the ABC transporter gene (3, 7),
so we thought that the higher level of constitutive expression of the
PMR1 gene could be responsible for the higher DMI resistance
of the resistant strains. However, introduction of the PMR1
coding region under the control of a strong constitutive promoter,
PgpdA, into a DMI-sensitive strain had no observable effect
on DMI resistance (H. Hamamoto, O. Nawata, K. Hasegawa, R. Nakaune,
Y. J. Lee, Y. Makizumi, K. Akutsu, and T. Hibi, submitted for
publication), suggesting that the constitutive expression level of
PMR1 is not the determinative factor for DMI resistance. The
coding sequences of this gene from three DMI-sensitive and three
DMI-resistant strains were also identical. These results suggested that
another factor was responsible for the higher DMI resistance (Hamamoto
et al., submitted).
Possible resistance mechanisms include mutations of CYP51,
the gene encoding cytochrome P450 sterol 14
-demethylase
(P45014DM), the target enzyme of DMIs (29), or
increased expression of CYP51 (11, 12). Our
initial objective in this study was to determine if DMI resistance is
attributable to these mechanisms associated with CYP51. We
found that a tandem repeat of a unique 126-bp sequence in the region
upstream of the CYP51 gene contributes to the overexpression of the gene and results in higher DMI resistance. To our knowledge, this is the first report of the acquisition of fungicide resistance triggered by a transcriptional enhancer in filamentous fungi.
 |
MATERIALS AND METHODS |
Fungal strains.
The three DMI-sensitive strains (PD5, DF1,
and U1) and the three DMI-resistant strains (LC2, M1, and I1) of
P. digitatum were field isolates of different origins
(21). The effective concentrations inhibiting radial growth
by 50% (EC50s), and the MICs of the DMI fungicide
triflumizole were 0.01 to 0.08 and 1 µg/ml, respectively, for the
sensitive strains and 1.3 to 2.8 and >100 µg/ml, respectively, for
the resistant strains (21). LC2M, a spontaneous mutant with diminished resistance, was isolated from the resistant strain LC2. The
EC50 and MIC of triflumizole for LC2M were 0.5 and 10 µg/ml, respectively. We previously sequenced PMR1 (GenBank
accession number AB010442), a gene encoding a toxicant-extruding ABC transporter, in LC2 and LC2M, and we observed no difference between the
nucleotide sequences in the two strains (data not shown). All of the
strains were stored as frozen spore suspensions at
80°C. These
strains were deposited in the Institute for Fermentation (IFO), Osaka,
Japan. IFO accession numbers are 33112 through 33118 for PD5, DF1, U1,
LC2, M1, I1, and LC2M, respectively.
Oligonucleotide primers.
The oligonucleotide primers we
designed for use in PCR and nucleotide sequencing are listed in Table
1. The positions of these primers
within and around the coding region of the P. digitatum CYP51 (PdCYP51) gene are shown in Fig.
1A.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Positions of the primers used for PCR, nucleotide
sequencing, and transformation experiments. Numeral components of
primer names are shown along boxes and lines, which represent the
PdCYP51 ORF and surrounding sequences, respectively. (B)
Schematic representation of the structure of the PdCYP51
gene of strain PD5. Open boxes, ORF; shaded boxes, introns. Six regions
encoding highly conserved CR domains are indicated below.
|
|
Cloning and sequencing of the putative PdCYP51
gene.
Based on the conserved amino acid sequences encoded by the
CYP51 genes of Penicillium italicum
(25), Ustilago maydis (10), Saccharomyces cerevisiae (14), and C. albicans (17), we designed a set of degenerate primers,
Pri 284 and Pri 1511c, to PCR amplify a genomic DNA fragment encoding
part of the PdCYP51 gene. The PCR conditions were as
follows: 3 min at 94°C followed by 30 cycles each of 30 s at
94°C, 1 min at 60°C, and 2 min at 72°C, using a GeneAmp 2400 or
9700 thermal cycler (Perkin-Elmer [PE] Applied Biosystems, Foster
City, Calif.) with Ex Taq polymerase (Takara, Tokyo, Japan). The
amplified 1.2-kb fragment was cloned into pGEM-T (Promega, Madison,
Wis.) and sequenced by following the instructions in the pGEM-T and
pGEM-T Easy Vector Systems technical manual (Promega). The sequence
obtained was used to design four inverse PCR (IPCR) primers: Pri 346c,
Pri 426c, Pri 926, and Pri 1230. Genomic DNA of PD5 was digested with
SalI or XhoI and was self-ligated in order to be
subjected to IPCR (22). The IPCR conditions were as follows:
3 min at 94°C followed by 30 cycles each of 30 s at 94°C,
30 s at 55°C, and 3 min at 72°C. The 1.2-kb IPCR products were
sequenced directly and contained putative initiation and termination
codons. Based on these sequences, we designed a set of primers, Pri
207 and Pri 1875c, to amplify the entire CYP51 gene. The
PCR conditions were as follows: 5 min at 94°C followed by 25 cycles
each of 30 s at 94°C, 30 s at 56°C, and 2.5 min at 72°C. The amplified 2.1-kb fragment was passed through a SUPREC-02 ultrafilter (Takara) to remove PCR primers. The concentrate was applied
to dye terminator labeling reactions by using a dRhodamine Terminator
Cycle Sequencing FS Ready Reaction Kit (PE Applied Biosystems) for
direct sequencing (Fig. 1A) on an ABI PRISM 377 HM or an ABI PRISM 310 (PE Applied Biosystems) DNA sequencer.
Reverse transcription (RT)-PCR was carried out as follows. Total RNA
was isolated from mycelia of strain PD5 grown in potato
dextrose broth
medium and subjected to RT with a 42-base oligo(dT)Sph
anchor primer
binding to poly(A) (Table
1) using GibcoBRL Superscript
(Life
Technologies, Rockville, Md.) according to the manufacturer's
instructions. The product of RT was first subjected to PCR with
Pri

207 and a 21-base TSP primer (Table
1) corresponding to
the
oligo(dT)Sph anchor primer. The PCR conditions were as follows:
3 min
at 94°C followed by 40 cycles each of 30 s at 94°C, 1 min
at
55°C, and 1.5 min at 72°C. The second PCR was carried out with
Pri

207 and Pri 1875c, and the product of the second PCR was
used for
sequencing. The conditions for the second PCR were as
follows: 3 min at
94°C followed by 25 cycles each of 30 s at 94°C,
1 min at
58°C, and 1 min at 72°C.
Southern and Northern blot analysis.
Extraction of genomic
DNA and total RNA, Southern and Northern blotting, hybridization, and
signal detection using the ECL system (Amersham Pharmacia Biotech UK,
Bucks, England) were performed as described previously (21).
The PCR product amplified with Pri
207 and Pri 1875c was passed
through a SUPREC-02 ultrafilter (Takara) and used as a probe to detect
the PdCYP51 gene in Southern and Northern blotting. For
blotting control, a cDNA fragment containing the actin gene
(actA) of P. digitatum was used. To examine the induction of gene expression by a DMI fungicide, the fungus was treated
with 50 µg of triflumizole/ml for 10 min in a liquid culture medium.
All the expression assays were carried out at least twice.
Cotransformation and toxicant sensitivity assay.
To obtain
the sequences upstream and downstream of PdCYP51, the IPCR
products were cloned into pGEM-T and sequenced. Based on the sequence
data, we designed four primers, Pri
1.8 k, Pri
1.5 k, Pri 3.3 kc,
and Pri 3.5 kc (Table 1; Fig. 1A). Pri
1.8k and Pri 3.5 kc were used
to amplify the putative promoter and coding region of the
PdCYP51 gene. Fragments of 5.3 kbp (PdCYP51-P) and 5.8 kbp (PdCYP51-L) were amplified from strains PD5 and
LC2, respectively. These clones were introduced into the DMI-sensitive strain PD5 by cotransformation with plasmid pBF101, which carries a
blasticidin S resistance cassette (15). Transformation was performed by the polyethylene glycol method as described by Itoh et al.
(13). For selection of blasticidin S-resistant
transformants, 100 µg of blasticidin S/ml was used. To isolate the
DMI-resistant transformants, conidia of blasticidin S-resistant lines
were inoculated onto potato dextrose agar (PDA) plates containing 0, 0.01, 0.1, 1.0, or 10.0 µg of triflumizole/ml, and germination and
growth were examined after incubation for 3 days at 25°C. For
determination of EC50s and MICs of DMIs and other
toxicants, the transformants were purified by subculture of single
spores, and EC50s and MICs were determined as described
previously (21). Experiments for each toxicant were carried
out at least three times. Toxicants tested included four DMIs
(triflumizole, fenarimol, bitertanol, and pyrifenox), one antibiotic
(cycloheximide), and two mutagens (acriflavine and
4-nitroquinoline-N-oxide [4NQO]).
Nucleotide sequence accession numbers.
The sequences of
PdCYP51 from PD5 and LC2 are available under GenBank
accession numbers AB030178 and AB030179, respectively.
 |
RESULTS |
Sequence and structure of the PdCYP51 gene of strain
PD5.
Southern blot analysis suggested that CYP51 is
present as a single-copy gene in the genome of P. digitatum
strain PD5 (data not shown). The PCR fragment amplified from genomic
DNA of P. digitatum strain PD5 with primers Pri
207 and
Pri 1875c was 2,082 bp long and had one putative open reading frame
(ORF) (nucleotides 1 to 1759) divided into four exons by three introns
(nucleotides 217 to 281, 480 to 548, and 1629 to 1702). The positions
of the introns were the same as those reported for P. italicum, and the excision of these introns was confirmed by
sequencing the RT-PCR product derived from the mRNA of this gene. The
deduced amino acid sequence of CYP51 had 87% similarity to that of
P. italicum and more than 40% similarity to CYP51 of
S. cerevisiae and C. albicans. The P. digitatum sequence contained six regions, CR1 through CR6 (encoded
by nucleotides 214 to 302 [containing intron 217 to 281], 405 to 455, 759 to 791, 981 to 1082, 1215 to 1235, and 1482 to 1541, respectively)
(Fig. 1B), known to be highly conserved among CYP51 family proteins
(1). We named this gene PdCYP51.
Sequence comparison of PdCYP51 genes in seven
strains.
Each of the seven P. digitatum strains studied
had a single copy of the PdCYP51 gene in its genome as
indicated by Southern blot analysis (data not shown). The PCR products
amplified with Pri
207 and Pri 1875c were separated by agarose gel
electrophoresis, and fragments of 2.1, 2.7, and 2.3 kb were observed
(Fig. 2A). When sequenced, the
PdCYP51 structural genes in all of the strains were
identical; however, there were apparent differences in the promoter
region. Each of the three resistant strains had a tandem repeat of five
copies of a unique 126-bp sequence, 5'
GGATCATTTTTGCTCCGGCTGGTGTGACATCTGGGGATGGCCTGACCTGATGATTAATCGTCAATCCTTCCCTCCTGATTTGTCTTACAAAACCCTAACTGTGTGGCCTCATACTTCCGATTCCAG 3', in the upstream promoter region between nucleotides
672 and
43. In all three sensitive strains this sequence was present only
once, while in LC2M, the number of copies was two (Fig. 2B). This
sequence was identical in every repeat and was repeated in tandem
without any intervening residues. Except for the difference in the
number of copies, the sequences of the upstream region amplified with
Pri
207 and Pri 1875c from all seven strains were identical. A BLAST
and FASTA database search based on the sequence of the repeat unit
identified no striking similarities to known sequences except for a
similar sequence (80% homology) observed in the region of nucleotides
173 to
47 in the promoter region of the CYP51 gene of
P. italicum (25). There is no apparent TATA box
or CCAAT box in the region upstream of PdCYP51.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 2.
Comparison of genomic PCR products derived from three
DMI-sensitive strains (PD5, DF1, and U1), three DMI-resistant strains
(LC2, M1, and I1), and the mutant strain LC2M, amplified with Pri 207
and Pri 1875c. (A) Ethidium bromide-stained image of the PCR products
separated in a 0.7% agarose gel. (B) Schematic representation of the
sequences of the PCR products derived from the seven strains. Each open
arrow represents one unit of the tandem repeat. Open box, ORF of
PdCYP51.
|
|
Expression of the PdCYP51 gene.
The levels of
accumulation of PdCYP51 mRNA (about 2.0 kb) in all three
DMI-resistant strains were much higher than those in the DMI-sensitive
strains (Fig. 3; autoradiograms were
slightly overexposed to show the bands of the sensitive strains). In
analyses with a shorter exposure time or diluted samples (data not
shown), the levels of PdCYP51 mRNA in the resistant strains
were shown to be approximately 100-fold higher than those in the
sensitive strains. In the autoradiograms, a second, larger band (about
3.5 kb) was observed, the nature of which is unknown. The level of PdCYP51 mRNA in LC2M was somewhat lower than that in LC2 but
higher than those in the sensitive strains. Treatment with the DMI
fungicide triflumizole had little effect on the expression level of
this gene. These results suggest that the 126-bp sequence in the
promoter region of PdCYP51 may be a transcriptional enhancer
and that additional copies increase the expression of
PdCYP51 and result in higher DMI resistance.

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 3.
Northern blot analysis of expression of the
PdCYP51 gene. (A) Expression without fungicide treatment.
(B) Expression after triflumizole (50 µg/ml) treatment for 10 min.
The RNA on the membrane was rehybridized with an actin gene
(actA)-specific probe to check for equal loading of RNA, and
the pattern is shown below.
|
|
Transformation of a DMI-sensitive strain with a PdCYP51
allele from a DMI-resistant strain.
PdCYP51-P (a 5.3-kb
fragment with a promoter with one repeat from PD5) or
PdCYP51-L (a 5.8-kb fragment with a promoter with five
repeats from LC2) was transformed into the DMI-sensitive strain PD5.
Cloning of the 5.8-kb fragment in the plasmid vector sometimes resulted
in deletion of the tandem repeats, so we introduced the PCR product
directly into the fungus by cotransformation with pBF101, which encodes
blasticidin S resistance. We first obtained 23, 21, and 12 blasticidin
S-resistant transformants following transformation with
PdCYP51-P plus pBF101, PdCYP51-L plus pBF101, and
pBF101 alone, respectively. Conidia from the nontransformed parental
strain and the 35 transformants obtained by the introduction of
PdCYP51-P plus pBF101 or pBF101 alone did not germinate on PDA plus 1 µg of triflumizole/ml. One transformant generated by the
introduction of PdCYP51-P plus pBF101, designated
PD5(PdCYP51-P)-21, germinated and grew on PDA plus 0.1 µg
of triflumizole/ml and had integrated one copy of PdCYP51-P
(data not shown). Conidia from 3 transformants obtained by the
introduction of PdCYP51-L plus pBF101 did germinate on PDA
plus 10 µg of triflumizole/ml, whereas the other 18 transformants did not germinate on PDA plus 1.0 µg of triflumizole/ml
and were shown by PCR analysis to harbor no PdCYP51-L gene
(data not shown). Two of the transformants acquiring increased DMI
resistance, PD5(PdCYP51-L)-7 and
PD5(PdCYP51-L)-15, had one and five copies of the foreign
PdCYP51-L, respectively (data not shown).
PdCYP51 mRNA levels were increased in
PD5(
PdCYP51-L)-7 and PD5(
PdCYP51-L)-15 to equal
that in LC2, but only a slight increase
was observed in
PD5(
PdCYP51-P)-21 (Fig.
4).
PD5(
PdCYP51-L)-7 and
PD5(
PdCYP51-L)-15 showed
significant increases in DMI resistance
(Table
2), and in the cases of triflumizole,
fenarimol, and bitertanol,
they were almost as resistant as LC2,
whereas PD5(
PdCYP51-P)-21
showed only a slight increase in
resistance. On the other hand,
the sensitivities of these transformants
to other toxicants remained
unchanged. These results suggest that the
126-bp tandem repeat
in the promoter enhances expression of
PdCYP51 and increases DMI
resistance in
P. digitatum.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 4.
Northern blot analysis of constitutive expression of the
PdCYP51 gene in the transformed PD5 lines
PD5(PdCYP51-P)-21, PD5(PdCYP51-L)-7, and
PD5(PdCYP51-L)-15. The RNA on the membrane was rehybridized
with an actin gene (actA)-specific probe to check for equal
loading of RNA, and the pattern is shown below.
|
|
 |
DISCUSSION |
DMI resistance in fungi could be acquired either as a result of
mutations in the CYP51 gene or as a result of an increased expression level of this gene (11, 12). In some
Candida species that cause oral candidiasis in AIDS
patients, the molecular mechanism of DMI resistance has been
intensively studied, and point mutations in CYP51 were
associated with increased DMI resistance (2, 18, 23, 27).
Also, in the phytopathogenic fungi P. italicum, Uncinula necator, and E. graminis, changes in the
amino acid sequence of CYP51 are associated with DMI resistance
(4, 5, 6).
Changes in the expression level of CYP51 might contribute to
the gradual development of DMI resistance (8, 20, 26). In
Candida glabrata, increased expression of CYP51
could occur due to an increase in CYP51 copy number
resulting from a chromosome duplication (20). Such a
mechanism for toxicant resistance is also known in mammalian systems as
gene amplification (24). However, the contribution of
increased expression of CYP51 to DMI resistance in field
isolates of phytopathogenic fungi is unknown.
With respect to the P. digitatum CYP51 gene,
PdCYP51, the protein-coding regions of the six alleles we
cloned were identical. More specifically, none of the three amino acid
residues, Tyr126, Ile313 and
Arg457, substitution at which has been reported to be
associated with DMI resistance (2, 4, 5, 6, 18, 23, 27),
were resistant-type residues. Thus, changes in the amino acid sequence
of the CYP51 protein were not responsible for the differences we
observed in DMI resistance. We did find a unique 126-bp sequence that
was tandemly repeated five times in the DMI-resistant strains. We have
further checked the presence of the tandem repeat in another seven
DMI-resistant strains and nine DMI-sensitive strains of P. digitatum by PCR with primers Pri
207 and 38c, and we have
confirmed that all resistant strains tested had a tandem repeat of five
copies of a 126-bp sequence, while all sensitive strains had only one
copy (H. Hamamoto et al., unpublished data). This 126-bp sequence may
act as a transcriptional enhancer, with the tandem repeat increasing
the level of expression of PdCYP51 and thereby conferring
DMI resistance. Also, the results of the transformation of PD5 with
PdCYP51 suggest that the copy number of PdCYP51
may have a small effect on the level of expression of this gene and DMI
resistance. This report is the first to show that overexpression of
CYP51 contributes to DMI resistance in phytopathogenic fungi.
Previously, we showed that PMR1, a gene encoding an ABC
transporter involved in toxicant extrusion, plays a role in DMI
resistance in P. digitatum and that a mutant in which
PMR1 was disrupted exhibited a loss of DMI resistance
(21). Considering these findings on PMR1 together
with the present results on CYP51, we hypothesize that DMI
sensitivity depends on the ratio of toxicant molecules to target enzyme
molecules inside the fungal cell. The number of toxicant molecules
inside the cell is controlled by PMR1, which extrudes to the outside of
the cell the intruding toxicant and/or the endogenous toxic
oxysterols accumulated by the action of DMI. The number of
target enzyme molecules is dependent on the level of expression
of CYP51. Therefore, when PMR1 and
CYP51 are expressed at ordinary levels, the fungi are DMI
sensitive. Also, when PMR1 is disrupted, the fungi are DMI
sensitive, even when CYP51 is overexpressed (21).
When PMR1 is expressed at an ordinary level and
CYP51 is overexpressed, the fungi exhibit resistance, as
shown in this study. It is also possible that the fungi will exhibit resistance if PMR1 is overexpressed at an extraordinary
level and CYP51 is expressed at an ordinary level, although
the strains used in the present study could not be used to test this hypothesis.
The mechanism by which the tandem repeat unit enhances the expression
of PdCYP51 remains to be determined. The 126-bp sequence contains four sites for known fungal transcriptional binding factors (ADR1 and HSF) and 15 sites for vertebrate binding factors [HNF3-
, CdxA, MZF1, GATA-1, GATA-2, Pbx-1, Elf-1, c/EBP
, v-Myb, and
c-Ets-1(p54)] (Fig. 5). Similar clusters
of transcription factor binding sites also occur in TATA-less promoter
sequences (19, 28, 30), so the 126-bp sequence might
function as both a transcriptional enhancer and a promoter.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 5.
Transcription factor binding sites within the 126-bp
sequence found by means of a computer search on the GenomeNet server
using the MOTIF program (The Supercomputer Laboratory, The Institute
for Chemical Research, Kyoto University [http://www.genome.ad.jp/]).
The sites found in the upper strand are shown above the sequence, and
the sites in the lower strand are shown below the sequence.
|
|
We do not know if the resistant strains were derived from sensitive
strains by mutation while under selection for fungicide resistance. We
did not detect any additional repeats in DMI-sensitive strains that had
been subcultured on PDA containing low concentrations of triflumizole
for 6 months. From LC2M, we know that a resistant strain can lose some
resistance by loss of some of the copies of the repeated sequence. At
present, we cannot explain how the copy number of the enhancer sequence increases.
This transcriptional enhancer-based mechanism is a new fungicide
resistance mechanism for filamentous fungi. Whether the mechanism also occurs in other filamentous fungi or plays a role in resistance to
toxicants other than DMIs remains to be determined. Finally, we think
that the strong enhancer activity of the tandem repeats might be a
useful tool to increase gene expression in other applied microbiology
and biotechnology contexts.
 |
ACKNOWLEDGMENTS |
This study was supported by the program for promotion of basic
research activities for innovative biosciences of the Bio-oriented Technology Research Advancement Institution (BRAIN).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory of
Plant Pathology, Department of Agricultural and Environmental Biology, The University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan. Phone: 81-3-5841-5054. Fax: 81-3-5841-5090. E-mail:
hirohama{at}ims.u-tokyo.ac.jp.
 |
REFERENCES |
| 1.
|
Aoyama, Y.,
M. Noshiro,
O. Gotoh,
S. Imaoka,
Y. Funae,
N. Kurosawa,
T. Horiuchi, and Y. Yoshida.
1996.
Sterol 14-demethylase P450 (P45014DM) is one of the most ancient and conserved P450 species.
J. Biochem.
119:926-933[Abstract/Free Full Text].
|
| 2.
|
Asai, K.,
N. Tsuchimori,
K. Okonogi,
J. R. Perfect,
O. Gotoh, and Y. Yoshida.
1999.
Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450.
Antimicrob. Agents Chemother.
43:1163-1169[Abstract/Free Full Text].
|
| 3.
|
Balzi, E., and A. Goffeau.
1995.
Yeast multidrug resistance: the PDR network.
J. Bioenerg. Biomembr.
27:71-76[CrossRef][Medline].
|
| 4.
|
Délye, C.,
L. Bousset, and M.-F. Corio-Costet.
1998.
PCR cloning and detection of point mutations in the eburicol 14 -demethylase (CYP51) gene from Erysiphe graminis f. sp. hordei, a "recalcitrant" fungus.
Curr. Genet.
34:399-403[CrossRef][Medline].
|
| 5.
|
Délye, C.,
F. Laigret, and M.-F. Corio-Costet.
1997.
A mutation in the 14 -demethylase gene of Uncinula necator that correlates with resistance to a sterol biosynthesis inhibitor.
Appl. Environ. Microbiol.
63:2996-2970.
|
| 6.
|
de Waard, M. A.
1996.
Molecular genetics of resistance in fungi to azole fungicides.
ACS Symp. Ser.
645:62-71.
|
| 7.
|
Endicott, J. A., and V. Ling.
1989.
The biochemistry of P-glycoprotein-mediated multidrug resistance.
Annu. Rev. Biochem.
58:137-171[CrossRef][Medline].
|
| 8.
|
Franz, R.,
S. L. Kelly,
D. C. Lamb,
D. E. Kelly,
M. Ruhnke, and J. Morschhäuser.
1998.
Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.
Antimicrob. Agents Chemother.
42:3065-3072[Abstract/Free Full Text].
|
| 9.
|
Fuchs, A., and C. A. Drandarevski.
1976.
The likelihood of development of resistance to systemic fungicides which inhibit ergosterol biosynthesis.
Neth. J. Plant Pathol.
82:85-87[CrossRef].
|
| 10.
|
Hargreaves, J. A., and J. P. R. Keon.
1996.
Isolation of an Ustilago maydis ERG11 gene and its expression in a mutant deficient in sterol 14 -demethylase activity.
FEMS Microbiol. Lett.
139:203-207[Medline].
|
| 11.
|
Hitchcock, C. A.
1993.
Resistance of Candida albicans to azole antifungal agents.
Biochem. Soc. Trans.
21:1039-1047[Medline].
|
| 12.
|
Hollomon, D. W.
1993.
Resistance to azole fungicides in the field.
Biochem. Soc. Trans.
21:1047-1051[Medline].
|
| 13.
|
Itoh, Y.,
R. Johnson, and B. Scott.
1994.
Integrative transformation of the mycotoxin-producing fungus Penicillium paxilli.
Curr. Genet.
25:508-513[CrossRef][Medline].
|
| 14.
|
Kalb, V. F.,
C. W. Woods,
T. G. Turi,
C. R. Dey,
T. R. Sutter, and J. C. Loper.
1987.
Primary structure of the P450 lanosterol demethylase gene from Saccharomyces cerevisiae.
DNA
6:529-537[Medline].
|
| 15.
|
Kimura, M.,
T. Kamakura,
Q. Z. Tao,
I. Kaneko, and I. Yamaguchi.
1994.
Cloning of the blasticidin S deaminase gene (BSD) from Aspergillus terreus and its use as a selectable marker for Schizosaccharomyces pombe and Pyricularia oryzae.
Mol. Gen. Genet.
242:121-129[CrossRef][Medline].
|
| 16.
|
Köller, W., and H. Scheinpflug.
1987.
Fungal resistance to sterol biosynthesis inhibitors: a new challenge.
Plant Dis.
71:1066-1074.
|
| 17.
|
Lai, M. H., and D. R. Kirsch.
1989.
Nucleotide sequence of cytochrome P450L1A1 (lanosterol 14 -demethylase) from Candida albicans.
Nucleic Acids Res.
17:804[Free Full Text].
|
| 18.
|
Lamb, D. C.,
D. E. Kelly,
W.-H. Schunck,
A. Z. Shyadehi,
M. Akhtar,
D. J. Lowe,
B. C. Baldwin, and S. L. Kelly.
1997.
The mutation T315A in Candida albicans sterol 14 -demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity.
J. Biol. Chem.
272:5682-5688[Abstract/Free Full Text].
|
| 19.
|
Luckhart, S., and R. Rosenberg.
1999.
Gene structure and polymorphism of an invertebrate nitric oxide synthase gene.
Gene
232:25-34[CrossRef][Medline].
|
| 20.
|
Marichal, P.,
H. V. Bossche,
F. C. Odds,
G. Nobels,
D. W. Warnock,
V. Timmerman,
C. van Broeckhoven,
S. Fay, and P. Mose-Larsen.
1997.
Molecular biological characterization of an azole-resistant Candida glabrata isolate.
Antimicrob. Agents Chemother.
41:2229-2237[Abstract].
|
| 21.
|
Nakaune, R.,
K. Adachi,
O. Nawata,
M. Tomiyama,
K. Akutsu, and T. Hibi.
1998.
A novel ATP-binding cassette transporter involved in multidrug resistance in the phytopathogenic fungus Penicillium digitatum.
Appl. Environ. Microbiol.
64:3983-3988[Abstract/Free Full Text].
|
| 22.
|
Ochman, H.,
A. S. Gerber, and D. L. Hartl.
1988.
Genetic application of an inverse polymerase chain reaction.
Genetics
12:621-623.
|
| 23.
|
Sanglard, D.,
F. Ischer,
L. Koymans, and J. Bille.
1998.
Amino acid substitutions in the cytochrome P-450 lanosterol 14 -demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
Antimicrob. Agents Chemother.
42:241-253[Abstract/Free Full Text].
|
| 24.
|
Schimke, R. T.
1984.
Gene amplification in cultured animal cells.
Cell
37:705-713[CrossRef][Medline].
|
| 25.
|
van Nistelrooy, J. G. M.,
J. M. van den Brink,
J. A. L. van Kan,
R. F. M. van Gorcom, and M. A. de Waard.
1996.
Isolation and molecular characterization of the gene encoding eburicol 14 -demethylase (CYP51) from Penicillium italicum.
Mol. Gen. Genet.
250:725-733[Medline].
|
| 26.
|
White, T. C.
1997.
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
Antimicrob. Agents Chemother.
41:1482-1487[Abstract].
|
| 27.
|
White, T. C.
1997.
The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14 -demethylase in Candida albicans.
Antimicrob. Agents Chemother.
41:1488-1494[Abstract].
|
| 28.
|
Wrehlke, C.,
W.-R. Wiedemeyer,
H.-P. Schmitt-Wrede,
A. Mincheva,
P. Lichter, and F. Wunderlich.
1999.
Genomic organization of mouse gene zfp162.
DNA Cell Biol.
18:419-428[CrossRef][Medline].
|
| 29.
|
Yoshida, Y., and Y. Aoyama.
1991.
Sterol 14 -demethylase and its inhibition: structural considerations on interaction of azole antifungal agents with lanosterol 14 -demethylase (P-45014DM) of yeast.
Biochem. Soc. Trans.
19:778-782[Medline].
|
| 30.
|
Zeng, G.,
L. Gao, and R. K. Yu.
1998.
Isolation and functional analysis of the promoter of the rat CMP-NeuAc:GM3 2,8 sialyltransferase gene.
Biochim. Biophys. Acta
1397:126-136[Medline].
|
Applied and Environmental Microbiology, August 2000, p. 3421-3426, Vol. 66, No. 8
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Luo, C.-X., Schnabel, G.
(2008). The Cytochrome P450 Lanosterol 14{alpha}-Demethylase Gene Is a Demethylation Inhibitor Fungicide Resistance Determinant in Monilinia fructicola Field Isolates from Georgia. Appl. Environ. Microbiol.
74: 359-366
[Abstract]
[Full Text]
-
Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Melchers, W. J. G., Verweij, P. E., Cuenca-Estrella, M., Rodriguez-Tudela, J. L.
(2007). A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations. Antimicrob. Agents Chemother.
51: 1897-1904
[Abstract]
[Full Text]
-
Ma, Z., Proffer, T. J., Jacobs, J. L., Sundin, G. W.
(2006). Overexpression of the 14{alpha}-Demethylase Target Gene (CYP51) Mediates Fungicide Resistance in Blumeriella jaapii. Appl. Environ. Microbiol.
72: 2581-2585
[Abstract]
[Full Text]
-
Sekine, M., Taya, C., Shitara, H., Kikkawa, Y., Akamatsu, N., Kotani, M., Miyazaki, M., Suzuki, A., Yonekawa, H.
(2006). The cis-Regulatory Element Gsl5 Is Indispensable for Proximal Straight Tubule Cell-specific Transcription of Core 2 beta-1,6-N-Acetylglucosaminyltransferase in the Mouse Kidney. J. Biol. Chem.
281: 1008-1015
[Abstract]
[Full Text]
-
Zwiers, L.-H., Stergiopoulos, I., Van Nistelrooy, J. G. M., De Waard, M. A.
(2002). ABC Transporters and Azole Susceptibility in Laboratory Strains of the Wheat Pathogen Mycosphaerella graminicola. Antimicrob. Agents Chemother.
46: 3900-3906
[Abstract]
[Full Text]